Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Co-Amoxiclav TEVA 1000 mg/200 mg Powder for Solution for Injection/Infusion – PA0749/011/002
- Cordarone X Intravenous 150mg/3ml Concentrate for Solution for Infusion or Slow Injection – PA0540/142/003
- Esomeprazole Krka 20mg Gastro-Resistant Capsule – PA1347/017/001
- Triapin 5mg/5mg Prolonged Release Tablet – PA0540/082/002
- Zerbaxa 1g/0.5g Powder for Concentrate for Solution for Infusion – EU/1/15/1032/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Arcoxia 120mg tablet – PA1997/001/004
- Blopress 2mg Tablet – PA2229/001/001
- Blopress 8mg Tablet – PA2229/001/003
- Elocon 0.1% w/w Ointment – PA1286/035/002
- Hypovase 0.5mg Tablet – PA0822/195/001
- Lipantil Micro 67mg Capsule – PA2010/015/001
- Marcain 0.25% Polyamp Steripack – PA1691/024/001
- Rebetol 40mg/ml Oral Solution – EU/1/99/107/004
- Tadalafil Krka 10mg Film Coated Tablet – PA1347/071/003
- Ultiva 2 mg Powder for Concentrate for Solution for Infusion – PA1691/032/002
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.